QR code

Effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF

Abstract The current study evaluated the effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF. 60 patients were randomized (1:1) to receive dapagliflozin 10 mg once daily, or placebo double blind for 1 year. Patients underwent transthor...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Qianyu Fu, Longhua Zhou, Yuqin Fan, Fenfen Liu, Yuanyuan Fan, Xin Zhang, Li Wang, Lan Cheng
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2023-11-01
Reeks:BMC Cardiovascular Disorders
Onderwerpen:
Dapagliflozin
Type 2 Diabetes
Heart Failure with reduced ejection fraction
Left ventricular remodeling
Echocardiography
Online toegang:https://doi.org/10.1186/s12872-023-03591-3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items